$2.18
+0.15 (+7.39%)
Open$2.06
Previous Close$2.03
Day High$2.18
Day Low$2.05
52W High$63.00
52W Low$1.43
Volume—
Avg Volume56.9K
Market Cap161.83M
P/E Ratio—
EPS$-0.08
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 66.78M | 62.47M | 71.10M |
| Net Income | 5.53M | 4.95M | 5.20M |
| Profit Margin | 8.3% | 7.9% | 7.3% |
| EBITDA | 7.58M | 8.61M | 8.78M |
| Free Cash Flow | 4.38M | 4.03M | 6.15M |
| Rev Growth | +15.6% | -3.5% | +12.7% |
| Debt/Equity | 0.23 | 0.21 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $262.82 | +1.11% | 72.8 | 459.33B |
| AMGN | Amgen Inc | $403.04 | -1.04% | 25.1 | 219.33B |
| GILD | Gilead Sciences Inc | $144.74 | -1.87% | — | 179.15B |
| VRTX | Vertex Pharmaceuticals Inc | $504.73 | -0.40% | 30.1 | 132.51B |
| REGN | Regeneron Pharmaceuticals | $735.20 | +0.05% | 17.4 | 75.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.72 | -4.96% | 36.9 | 29.82B |